In 2011, Sanofi US launched Data Design Diabetes (DDD), a next-generation open innovation challenge series seeking service solutions to improve the experience or outcome of the 29 million people in the United States living with diabetes.
At the launch, Dennis Urbaniak, then Vice President, US Diabetes, sanofi-aventis, appealed to all innovators to “take on this challenge, regardless of your background and current areas of interest.” Dennis explained that Sanofi’s crowdsourced approach sought to tap the distributed intelligence of the innovation community to “literally improve the quality of life for millions of Americans as well as spur new approaches that help us change the landscape of diabetes care in the US.”
Designed for speed and entrepreneurship – all participants retained full ownership of intellectual property – DDD is widely credited with shaping the pharmaceutical industry’s approach to open innovation and was featured in the White House’s first Open Innovator’s Toolkit.
DDD sent out its first open call to entrepreneurs in 2011, seeking solutions that coupled open data sets, such as those found on healthdata.gov, with a human-centered approach. Read more about the 2011 “Next Generation” Challenge.
In 2012, DDD focused on identifying solutions that improve the quality, delivery and cost of care. To give the Challenge shape, Sanofi asked the public to voice their opinions about what matters most in the relationships, priorities and experience of diabetes. The results of this crowdsourcing activity were woven throughout the criteria. Read more about the 2012 “What Matters Most?” Challenge.
In its final year, DDD asked innovators to find ways using open data to unlock critical insight to improve patient experience, clinical outcomes and economic realities. Read more about the 2013 “Prove It!” Challenge.
© 2015 The DX: The Diabetes Experience